Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $9 - $43
-5 Reduced 2.18%
224 $0
Q2 2022

Jul 22, 2022

SELL
$2.13 - $9.01 $21 - $90
-10 Reduced 4.18%
229 $0
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $23,173 - $57,527
-3,690 Reduced 93.92%
239 $1,000
Q4 2021

Feb 09, 2022

BUY
$14.7 - $28.67 $29,400 - $57,340
2,000 Added 103.68%
3,929 $59,000
Q3 2021

Nov 09, 2021

SELL
$24.31 - $33.6 $77,670 - $107,352
-3,195 Reduced 62.35%
1,929 $55,000
Q2 2021

Jul 08, 2021

SELL
$26.09 - $40.4 $5,139 - $7,958
-197 Reduced 3.7%
5,124 $170,000
Q1 2021

Jun 17, 2021

BUY
$33.06 - $56.93 $33 - $56
1 Added 0.02%
5,321 $185,000
Q4 2020

May 19, 2021

BUY
$39.09 - $57.4 $3,752 - $5,510
96 Added 1.84%
5,320 $180,000
Q3 2020

Sep 07, 2021

SELL
$28.43 - $44.67 $90,976 - $142,944
-3,200 Reduced 37.99%
5,224 $233,000
Q2 2020

Sep 07, 2021

BUY
$11.71 - $30.29 $61,184 - $158,265
5,225 Added 163.33%
8,424 $234,000
Q1 2020

Sep 07, 2021

BUY
$7.64 - $27.5 $22,729 - $81,812
2,975 Added 1328.13%
3,199 $45,000
Q3 2019

Sep 07, 2021

SELL
$18.85 - $27.5 $9,425 - $13,750
-500 Reduced 69.06%
224 $4,000
Q2 2019

Sep 07, 2021

BUY
$17.37 - $26.27 $8,685 - $13,135
500 Added 223.21%
724 $17,000
Q3 2018

Sep 07, 2021

BUY
$7.54 - $18.31 $1,688 - $4,101
224 New
224 $3,000
Q2 2018

Sep 07, 2021

SELL
$4.87 - $8.42 $3,647 - $6,306
-749 Closed
0 $0
Q4 2017

Sep 07, 2021

BUY
$7.86 - $9.99 $1,760 - $2,237
224 Added 42.67%
749 $6,000
Q2 2017

Sep 07, 2021

BUY
N/A
525
525 $5,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.